Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans

Synapse

Volumn 31, Issue 4, 1999, Pages 302-308

  Kegeles, Lawrence S ^a,b   Zea Ponce, Yolanda ^a   Abi Dargham, Anissa ^a   Rodenhiser, Janine ^a   Wang, Theodore ^a   Weiss, Richard ^a   Van Heertum, Ronald L ^a   Mann, J John ^a   Laurelle, Marc ^a  

^a Division of Brain Imaging ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Binding potential; Constant infusion; Intraclass correlation; Radioligand; Sensitization

Indexed keywords

AMPHETAMINE; IODINE 123; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 6 METHOXYSALICYLAMIDE; RADIOLIGAND; 3 IODO 2 HYDROXY 6 METHOXY N ((1 ETHYL 2 PYRROLIDINYL)METHYL)BENZAMIDE; 3-IODO-2-HYDROXY-6-METHOXY-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)BENZAMIDE; BENZAMIDE DERIVATIVE; DIAGNOSTIC AGENT; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; PYRROLIDINE DERIVATIVE; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG BLOOD LEVEL; DRUG SENSITIZATION; DRUG TOLERANCE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SIGNAL NOISE RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ALGORITHM; BEHAVIOR; BLOOD; CLINICAL TRIAL; DRUG EFFECT; IMAGE PROCESSING; ISOTOPE LABELING; METABOLISM; NEOSTRIATUM; SCINTISCANNING; SYNTHESIS;

ADULT; ALGORITHMS; AMPHETAMINE; BEHAVIOR; BENZAMIDES; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; ISOTOPE LABELING; MALE; NEOSTRIATUM; PYRROLIDINES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033558380     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(19990315)31:4<302::AID-SYN9>3.0.CO;2-A     Document Type: Article

References (43)

1. Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M,van Dyck CH, Charney DS, Innis RB, Laruelle M. 1998. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 155:761-767.
2. Akimoto K, Hamamura T, Kazahaya Y, Akiyama K, Otsuki S. 1990. Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine - an in vivo dialysis study in freely moving rats. Brain Res 507:344-346.
3. Angrist BM, Gershon S. 1970. The phenomenology of experimentally induced amphetamine psychosis-Preliminary observation. Biol Psychiatry 2:95-107.
4. Becker JB. 1990. Estrogen rapidly potentiates amphetamine-induced dopamine release and rotational behavior during microdialysis. Neurosci Lett 118:169-171.
5. Becker JB, Cha J. 1989. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav Brain Res 35:117-125.
6. Bischoff S, Krauss J, Grunenwald C, Gunst F, Heinrich M, Schaub M, Stocklin K, Vassout A, Waldmeier P, Maitre L. 1991. Endogenous dopamine (DA) modulates [3H]spiperone binding in vivo in rat brain. J Recept Res 11:163-175.
7. Booij J, Korn P, Linszen DH, vanRoyen EA. 1997. Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography. Eur J Nucl Med 24:674-677.
8. Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, deBartolomeis A, Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D. 1997. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94:2569-2574.
9. Carson RE, Breier A, deBartolomeis A, Saunders RC, Su TP, Schmall B, Der MG, Pickar D, Eckelman WC. 1997. Quantification of amphetamine-induced changes in [C-11]raclopride binding with continuous infusion. J Cereb Blood Flow Metab 17:437-447.
10. Caster SA, Xia L, Becker JB. 1993. Sex differences in striatal dopamine: in vivo microdialysis and behavioral studies. Brain Res 610:127-134.
11. Dewey SL, Brodie JD, Fowler JS, MacGregor RR, Schyler DJ, King PT, Alexoff DL, Volkow ND, Shiue CY, Wolf AP, Bendriem B. 1990. Positron Emission Tomography (PET) studies of dopamine/cholinergic interaction in the baboon brain. Synapse 6:321-327.
12. Grace AA. 1995. The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug Alcohol Depend 37:111-129.
13. 2 receptor in non-human primates. Synapse 10:177-184.
14. Kalivas P, Duffy P. 1990. The effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5:48-58.
15. Kalivas PW, Sorg BA, Hooks MS. 1993. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 4:315-334.
16. Kalivas PW, Stewart J. 1991. Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res Review 16:223-244.
17. Kazahaya Y, Akimoto K, Saburo O. 1989. Subchronic methamphetamine treatment enhances methamphetamine-or cocaine induced dopamine efflux in vivo. Biol Psychiatry 25:903-912.
18. Kirk RE. 1982. Experimental design: procedures for the behavioral sciences. California: Brooks/Cole publishing company.
19. 125I]IBZM: A potential CNS D-2 dopmaine receptor imaging agent. Nucl Med Biol 15:195-201.
20. 123I]IBZM, a potential dopamine D-2 receptor imaging agent. J Lab Comp Radiopharm 27:691-700.
21. Laruelle M, Abi-Dargham A,van Dyck CH, Gil R, De Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB. 1996. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug free schizophrenic subjects. Proc Natl Acad Sci USA 93:9235-9240.
22. Laruelle M, Abi-Dargham A,van Dyck CH, Rosenblatt W, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Charney DS, Hoffer PB, Kung HF, Innis RB. 1995. SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 36:1182-1190.
23. Laruelle M, Baldwin RM, Rattner Z, Al-Tikriti MS, Zea-Ponce Y, Zoghbi SS, Charney DS, Price JC, Frost JJ, Hoffer PB, Innis RB. 1994a. SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates. I. Kinetic modeling of single bolus experiments. J Cereb Blood Flow Metab 14:439-452.
24. Laruelle M, Iyer RN, Al-Tikriti MS, Zea-Ponce Y, Malison R, Zoghbi SS, Baldwin RM, Kung HF, Charney DS, Hoffer PB, Innis RB, Bradberry CW. 1997. Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse 25:1-14.
25. 2 receptors in healthy subjects. J Nucl Med 35:743-754.
26. 3H]raclopride. Proc Natl Acad Sci USA 86: 6412-6416.
27. Miller DW, Abercrombie ED. 1996. Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats. Brain Res Bull 40:57-62.
28. Patrick SL, Thompson TL, Walker JM, Patrik RL. 1991. Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus. Brain Res 538:343-346.
29. Paulson PE, Robinson TE. 1995. Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19:56-65.
30. Pettit HO, Pan HT, Parsons LH, Justice JBJ. 1990. Extracellular concentration of cocaine and dopamine are enhanced during chronic cocaine administration. J Neurochem 55:798-804.
31. Reimer ML, Mamer OA, Zavitsanos AP, Siddiqui AW, Dadgar D. 1993. Determination of amphetamine, metamphetamine and desmethyldeprenyl in human plasma by gas chromatography/negative ion chemical ionization mass spectrometry. Biol Mass Spectrom 22:235-42.
32. Robinson PH, Jurson PA, Bennet JA, Bentgen KM. 1988. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res 462:211-222.
33. Robinson TE, Becker JB. 1986. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Review 11:157-198.
34. Satel SL, Soutwick S, Gawin F. 1991. Clinical features of cocaine-induced paranoia. Am J Psychiatry 148:495-499.
35. Sato M, Chen CC, Akiyama K, Otsuki S. 1983. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry 18:429-440.
36. 2 receptors in schizophrenia and antipsychotic activity. Int Clin Psychopharmacol 8:25-32.
37. 3H]raclopride: Implications for positron emission tomography of the human brain. Synapse 3:96-97.
38. 2 receptors in human subjects with iodine-123-IBZM. J Nucl Med 33:1964-1971.
39. Strakowski SM, Sax KW, Setters MJ, Keck PE, Jr. 1996. Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol Psychiatry 40:872-880.
40. Thompson TL, Moss RL. 1997. Modulation of mesolimbic dopaminergic activity over the rat estrous cycle. Neurosci Lett 229:145-148.
41. van Kammen DP, Murphy DL. 1975. Attenuation of the euphoriant and activating effects of d-and l-amphetamine by lithium carbonate treatment. Psychopharmacologia (Berl) 44:215-224.
42. Woods RP, Cherry SR, Mazziotta JC. 1992. Rapid automated algorithm for aligning and reslicing PET images. J Comp Assist Tomogr 16:620-633.
43. Xiao L, Becker JB. 1994. Quantitative microdialysis determination of extracellular striatal dopamine concentration in male and female rats: effects of estrous cycle and gonadectomy. Neurosci Lett 180:155-158.